In this study, we evaluated the diagnostic value of mSEPT9 for blood-based CRC detection in Chinese patients, compared with traditional screening method (FOBT) and two blood-based tumor biomarkers (CEA and Ca-199). This evidence concerns the gene CEACAM5 and colorectal carcinoma.